NO20055725D0 - Glutamatreseptorantagonister som neurobeskyttende midler - Google Patents

Glutamatreseptorantagonister som neurobeskyttende midler

Info

Publication number: NO20055725D0
Authority: NO; Norway
Prior art keywords: receptor antagonists; glutamate receptor; neuroprotective agents; neuroprotective; agents
Prior art date: 2003-05-05

Application number

NO20055725A

Other languages

English (en)

Other versions

NO20055725L (no

Inventor

Wolfgang Sohngen

Original Assignee

Paion Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-05

Filing date

2005-12-02

Publication date

2005-12-02

2005-12-02 Application filed by Paion Deutschland Gmbh filed Critical Paion Deutschland Gmbh

2005-12-02 Publication of NO20055725L publication Critical patent/NO20055725L/no

2005-12-02 Publication of NO20055725D0 publication Critical patent/NO20055725D0/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Psychology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Plant Substances (AREA)
Peptides Or Proteins (AREA)

NO20055725A 2003-05-05 2005-12-02 Glutamatreseptorantagonister som neurobeskyttende midler NO20055725D0 (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DE10337098		2003-05-05
DE10320336		2003-05-06
DE10352333		2003-11-06
PCT/EP2004/004776 WO2004098635A1 (de)	2003-05-05	2004-05-05	Glutamat-rezeptor-antagonisten als neuroprotektiva

Publications (2)

Publication Number	Publication Date
NO20055725L NO20055725L (no)	2005-12-02
NO20055725D0 true NO20055725D0 (no)	2005-12-02

Family

ID=33436868

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055725A NO20055725D0 (no)	2003-05-05	2005-12-02	Glutamatreseptorantagonister som neurobeskyttende midler

Country Status (12)

Country	Link
US (1)	US20080213244A1 (no)
EP (1)	EP1622640A1 (no)
JP (1)	JP2006525277A (no)
KR (1)	KR20060015721A (no)
AU (1)	AU2004237407A1 (no)
BR (1)	BRPI0410055A (no)
CA (1)	CA2524342A1 (no)
EA (1)	EA200501753A1 (no)
HR (1)	HRP20050898A2 (no)
MX (1)	MXPA05011762A (no)
NO (1)	NO20055725D0 (no)
WO (1)	WO2004098635A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10153601A1 (de) *	2001-11-02	2003-05-22	Paion Gmbh	DSPA zur Behandlung von Schlaganfall
US20080057050A1 (en) *	2003-05-02	2008-03-06	Paion Deutschland Gmbh	Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
AU2006261099A1 (en) *	2005-06-24	2006-12-28	Wilex Ag	Use of Urokinase inhibitors for the treatment and/or prevention of neuropathological diseases
AR068914A1 (es) *	2007-10-18	2009-12-16	Paion Deutschland Gmbh	Uso de un activador de plasminogeno para la preparacion de un medicamento para el tratamiento de apoplejia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5786187A (en) *	1995-09-21	1998-07-28	The Research Foundation Of State University Of New York	Method for reducing neuronal degeneration associated with seizure
DE10153601A1 (de) *	2001-11-02	2003-05-22	Paion Gmbh	DSPA zur Behandlung von Schlaganfall

2004
- 2004-05-05 US US10/555,583 patent/US20080213244A1/en not_active Abandoned
- 2004-05-05 BR BRPI0410055-7A patent/BRPI0410055A/pt not_active IP Right Cessation
- 2004-05-05 EP EP04731137A patent/EP1622640A1/de not_active Withdrawn
- 2004-05-05 AU AU2004237407A patent/AU2004237407A1/en not_active Abandoned
- 2004-05-05 HR HR20050898A patent/HRP20050898A2/xx not_active Application Discontinuation
- 2004-05-05 MX MXPA05011762A patent/MXPA05011762A/es not_active Application Discontinuation
- 2004-05-05 CA CA002524342A patent/CA2524342A1/en not_active Abandoned
- 2004-05-05 WO PCT/EP2004/004776 patent/WO2004098635A1/de not_active Ceased
- 2004-05-05 KR KR1020057021076A patent/KR20060015721A/ko not_active Withdrawn
- 2004-05-05 EA EA200501753A patent/EA200501753A1/ru unknown
- 2004-05-05 JP JP2006505376A patent/JP2006525277A/ja active Pending
2005
- 2005-12-02 NO NO20055725A patent/NO20055725D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20060015721A (ko)	2006-02-20
MXPA05011762A (es)	2006-03-30
JP2006525277A (ja)	2006-11-09
HRP20050898A2 (en)	2007-03-31
NO20055725L (no)	2005-12-02
EP1622640A1 (de)	2006-02-08
US20080213244A1 (en)	2008-09-04
CA2524342A1 (en)	2004-11-18
BRPI0410055A (pt)	2006-04-25
WO2004098635A1 (de)	2004-11-18
AU2004237407A1 (en)	2004-11-18
EA200501753A1 (ru)	2006-04-28

Publication	Publication Date	Title
DK1562595T3 (da)	2008-08-18	Diarylethere som opioidreceptorantagonister
DK1723116T3 (da)	2009-02-02	Tetrahydroquinolinoner og deres anvendelse som antagonister for metabotropiske glutamatreceptorer
ATE413400T1 (de)	2008-11-15	Cgrp-rezeptorantagonisten
DK1682142T3 (da)	2012-10-15	M3-muscarin-acetylcholin-receptor-antagonister
DK1309559T3 (da)	2006-10-02	4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister
NO20052739D0 (no)	2005-06-07	CCR5-antagonister som medikamenter
DK1663996T3 (da)	2012-10-01	(Thio)carbamoylcyclohexanderivater som D3/D2-receptorantagonister
ATE557036T1 (de)	2012-05-15	Ox40 rezeptor bindende agenzien
DK1951660T3 (da)	2014-01-27	Histamin-3-receptorantagonister
NO20054951D0 (no)	2005-10-25	Prostaglandinanaloger som EP4-reseptorantagonister
NO20044325L (no)	2004-12-16	4-anilinokinazolinderivater som antiproliferative midler
DE60328925D1 (de)	2009-10-01	Jittergenerator
NO20043536L (no)	2004-08-24	Fluorsubstituerte sykloalkanoindoler og deres anvendelse som prostaglandin D2-reseptorantagonister
NO20051042L (no)	2005-03-31	Pyrimidylsulfonamidderivater som kemokinreseptormodulatorer
DK1833791T3 (da)	2011-10-24	2,3,4,9-tetrahydor-1H-carbazolderivater som CRTH2 receptorantagonister
DK1711465T3 (da)	2008-03-31	Hydroisoindolin-tachykinikreceptorantagonister
DK1761519T3 (da)	2008-07-21	Indolderivater som histaminreceptorantagonister
ATE432282T1 (de)	2009-06-15	2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
DK1305319T3 (da)	2006-08-14	4-phenyl-pyridinderivater som neurokinin-1-receptorantagonister
DK1636206T3 (da)	2008-02-11	Imidazolderivater som glutamatreceptorantagonister
DK1973886T3 (da)	2013-03-18	Prokineticin-1-receptor-antagonister
NO20044373L (no)	2004-10-14	Azetidinderivater som CCR-3-reseptorantagonister
DE60316411D1 (de)	2007-10-31	Thiazolderivate als npy-rezeptorantagonisten
ATE469875T1 (de)	2010-06-15	Nk1-antagonisten
DK1648882T3 (da)	2008-11-24	3-fluor-piperidiner som NMDA/NR2B-antagonister

Legal Events

Date	Code	Title	Description
2009-12-21	FC2A	Withdrawal, rejection or dismissal of laid open patent application